The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...

A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...

In a precedential opinion issued on Monday, the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated and remanded a ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...

Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this ...

Globally, people get animal protein mostly from chickens, with pigs and cattle in second and third place. A 2023 report ...

CRISPR Therapeutics faces challenges with a 20% stock drop, slow Casgevy commercialization, and regulatory hurdles. Read more ...

Emma Dimery joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today.

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...